Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
41.7%
% of IHE's 37 holdings also in FTXH
30.0%
% of FTXH's 51 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 24.4% | 8.1% | 8.1% |
|
PFIZER INC | 4.3% | 7.1% | 4.3% |
|
MERCK & CO. INC. | 4.2% | 7.1% | 4.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% | 7.0% | 4.1% |
|
ELI LILLY & CO | 25.8% | 3.9% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to FTXH
|
ELI LILLY & CO | 21.9% |
|
JOHNSON & JOHNSON | 16.3% |
|
ROYALTY PHARMA PLC CLASS A | 5.0% |
|
CORCEPT THERAPEUTICS INC | 2.1% |
|
AXSOME THERAPEUTICS, INC. | 1.5% |
|
PRESTIGE BRANDS HOLDINGS INC | 1.0% |
|
LIGAND PHARMACEUTICALS-CL B | 0.9% |
|
ZOETIS INC | 0.9% |
|
TARSUS PHARMACEUTICALS, INC. | 0.8% |
|
SUPERNUS PHARMACEUTICALS INC | 0.8% |
IHE Underweight Relative to FTXH
|
ABBVIE INC | -7.0% |
|
GILEAD SCIENCES INC | -3.9% |
|
AMGEN INC | -3.8% |
|
UNITED THERAPEUTICS CORP | -3.8% |
|
BIOGEN IDEC INC | -3.6% |
|
REGENERON PHARMACEUTICALS | -3.4% |
|
MERCK & CO. INC. | -2.9% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |
|
PFIZER INC | -2.7% |
|
EXELIXIS INC | -2.1% |